Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.51 |
| ▸ | CA4 | P22748 | 3/20 | 0.51 |
| ▸ | CA5A | P35218 | 3/20 | 0.51 |
| ▸ | CA7 | P43166 | 3/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.46 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.46 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18068230 | 1.00 | CA1 (0.51) | CA1CA2CA12CA4CA5A | |
| SCHEMBL2539365 | 0.99 | CA1 (0.49) | CA1CA2CA12CA4CA5A | |
| SCHEMBL3665513 | 0.92 | CA1 (0.50) | CA1CA2CA12CA4CA5A | |
| SCHEMBL7024538 | 0.92 | LGALS3 (0.49) | CA1CA2CA12CA4CA5A | |
| SCHEMBL7030017 | 0.92 | LGALS3 (0.52) | CA1CA2CA12CA4CA5A | |
| SCHEMBL7023852 | 0.92 | LGALS3 (0.52) | CA1CA2CA12CA4CA5A | |
| SCHEMBL7024531 | 0.92 | LGALS3 (0.52) | CA1CA2CA12CA4CA5A | |
| SCHEMBL18942413 | 0.91 | USP2 (0.51) | CA1CA2CA12CA4CA5A | |
| SCHEMBL18067750 | 0.89 | LGALS9 (0.44) | CA1CA2CA12CA4CA5A | |
| SCHEMBL5899337 | 0.89 | LGALS3 (0.56) | CA1CA2CA12CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10287309-B2 | Disaccharide intermediate and synthesis method thereof | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2019-05-14 | — | — | US | disclosed |
| EP-3070094-A1 | DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF | Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) | 2016-09-21 | — | — | EP | disclosed |
| US-20160264609-A1 | DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10287309-B2 | Disaccharide intermediate and synthesis method thereof | SI, FUT5, HPSE | CA1 441/4885CA2 1436/4885CA12 108/4885 |
| US-20160264609-A1 | DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF | SI, FUT5, HPSE | CA1 441/4885CA2 1436/4885CA12 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.